Zealand Pharma — Oktober 2022
-
-
Fonde under Polar Capital : https://www.polarcapital.co.uk/gb/professional/Our-Funds/Funds-Overview/#
-
Godmorgen.
-
Godmorgen.
-
Zealand Pharma/Jefferies: Kursmål hæves til 205 kr. fra 165 kr. - NY https://www.proinvestor.com/investornyt/889239/zealand-pharma-jefferies-kursmal-haeves-til-205-kr-fra-165-kr-ny
-
Aktier/tendens: Chr. Hansen kan stjæle fokus - C25 ses åbne rødt - NY https://www.proinvestor.com/investornyt/889256/aktier-tendens-chr-hansen-kan-stjaele-fokus-c25-ses-abne-rodt-ny
-
Mornings - spændende om momentum fortsætter i dag - mit højre knæ visker snart-200:)
-
hvisker...omg
-
-
Michael Novod’s rapport i dag: Zealand Pharma - Buy/DKK 245: Amgen rallies 6%, adding USD ~7bn to its market cap on a ph I obesity asset - shows exactly how underappreciated the Zealand obesity pipeline is.
-
super info - tak
-
Er vi på vej mod det ringeste porteføljeafkast i næsten 100 år? Hansen og Larsen ser lys forude på trods af et historisk dårligt 2022. De kommer også omkring to store danske selskaber, der har fået hug for deres kvartalsregnskaber. Bliv opdateret på hele ugen på en halv time med afsnit 139 af Investeringspodcasten. https://www.proinvestor.com/boards/106902
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind